Current studies seeking participants:
AIM HIGH
Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglyceride and Impact on Global Health Outcomes
The AIM HIGH Study is a multicenter, randomized clinical trial designed to evaluate whether two blood cholesterol lowering drugs (simvastatin and extended release niacin) are more effective than simvastatin alone in reducing the risk of heart attacks, strokes and other heart-related complications.
Enrollment is November, 2005 – November 2007. Follow-up through 2010
Candidates must be 45 years of age or older, have cardiovascular disease, and an imbalance of good and bad cholesterol (ie, low HDL cholesterol plus elevated triglycerides.)
AIM HIGH is sponsored by the National Heart, Lung, and Blood Institute with additional support from Kos Pharmaceuticals. Interested individuals can call DCRP at 1-877-807-9590
Investigators: Gregory Doelle, MD, William Sivitz, MD, Susan Beck, RN, Linda Larson, RN, Meg Bayless, RN
The effect of the menstrual cycle on blood glucose control in women with type 1 diabetes:
Purpose: To see if there are repetitive patterns of blood sugar control between cycles that may allow us to tailor insulin therapy to achieve better glucose control.
Personnel: Whitney Goldner MD, Vicki Kraus, PhD ARNP, Joseph Dillon MD, Stephen Hunter MD, William Sivitz, MD
Health related quality of life for patients with charcot foot:
Purpose: To assess the impact of Charcot Foot/Ankle disease on quality of life on people who have diabetes. For more details call 319-353-7659.
http://www.uihealthcare.com/depts/clinicaltrials/index.html
Post Meal Glycemia
The Post-Meal Glycemia Study is designed to look at the relationship between caloric intake and the blood glucose excursions after a subsequent meal in adult individuals with type 1 Diabetes Mellitus using insulin pumps. Three visits are required: one screening visit and two study visits lasting 6-8 hours. Compensation is available. Support for this research is from a grant from the Veteran’s Administration.
Interested individuals may call DCRP: 1-877-807-9590
Investigators: Rinku Mehra, MD, William Sivitz, MD, Meg Bayless, RN
|